SULPHASALAZINE IN RHEUMATOID-ARTHRITIS

被引:184
作者
MCCONKEY, B
AMOS, RS
DURHAM, S
FORSTER, PJG
HUBBALL, S
WALSH, L
机构
关键词
D O I
10.1136/bmj.280.6212.442
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:442 / 444
页数:3
相关论文
共 14 条
  • [1] BARNETSON RS, 1976, LANCET, V2, P1171
  • [2] HOLM G, 1968, ADV TRANSPLANT, P155
  • [3] KUZELL WILLIAM C, 1950, CALIFORNIA MED, V73, P476
  • [4] MCCONKEY B, 1972, Q J MED, V41, P115
  • [5] MCCONKEY B, 1973, Q J MED, V42, P785
  • [6] SALAZOPYRIN IN RHEUMATOID-ARTHRITIS
    MCCONKEY, B
    AMOS, RS
    BUTLER, EP
    CROCKSON, RA
    CROCKSON, AP
    WALSH, L
    [J]. AGENTS AND ACTIONS, 1978, 8 (04): : 438 - 441
  • [7] EFFECTS OF GOLD, DAPSONE, AND PREDNISONE ON SERUM C-REACTIVE PROTEIN AND HAPTOGLOBIN AND THE ERYTHROCYTE SEDIMENTATION-RATE IN RHEUMATOID-ARTHRITIS
    MCCONKEY, B
    DAVIES, P
    CROCKSON, RA
    CROCKSON, AP
    BUTLER, M
    CONSTABLE, TJ
    AMOS, RS
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1979, 38 (02) : 141 - 144
  • [8] RUBINSTEIN A, 1978, CLIN EXP IMMUNOL, V33, P217
  • [9] MEGALOBLASTIC-ANEMIA ASSOCIATED WITH SULFASALAZINE TREATMENT
    SCHNEIDER, RE
    BEELEY, L
    [J]. BRITISH MEDICAL JOURNAL, 1977, 1 (6077) : 1638 - 1639
  • [10] SCHRODER H, 1972, CLIN PHARMACOL THER, V13, P539